
    
      A single centre, randomised, partially blinded placebo-controlled repeat dose study in
      healthy male subjects to compare the effect of two different formulations of PrEP-001 nasal
      powder on nasal mucosal and serum cytokine profiles when dosed for up to five days in health
      subjects and provide additional safety and tolerability information on active PrEP-001 nasal
      powder.
    
  